Common Bile Duct Pressure After Surgical Exploration

Sponsor
Carlos R. Cervantes Sanchez (Other)
Overall Status
Completed
CT.gov ID
NCT04968873
Collaborator
(none)
13
1
8

Study Details

Study Description

Brief Summary

A study that included patients of any gender between 15 and 70 years, with the diagnosis of choledocholithiasis who required a cholecystectomy with an exploration of bile ducts. Conventional cholecystectomy was performed and a T-tube was inserted in the common bile duct (CBD) to measure the intraluminal pressure immediately after the procedure, and weekly thereafter, with a 6-week follow-up. A control T-tube radiological study was performed at six weeks to exclude residual stones.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cholecystectomy and common bile duct exploration
N/A

Detailed Description

A clinical, controlled, prospective, longitudinal, descriptive, observational and double-blinded study was designed. Patients of any gender between 15 and 70 years, with a diagnosis of choledocholithiasis, and who required a cholecystectomy with an exploration of bile ducts were included. Conventional cholecystectomy was performed and perioperative T-tube CBD pressure was registered immediately after the procedure, and weekly thereafter, with a 6-week follow-up.

Control T-tube cholangiogram was performed at six weeks to exclude residual stones. Data was analyzed with T-test for parametric values.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Common Bile Duct Pressure After Intraoperative Instrumentation in Patients With Uncomplicated Choledocholithiasis
Actual Study Start Date :
Mar 1, 2001
Actual Primary Completion Date :
Aug 1, 2001
Actual Study Completion Date :
Nov 1, 2001

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients with Choledocholithiasis

Patients were managed by elective open cholecystectomy and operative exploration of the common bile duct.

Procedure: Cholecystectomy and common bile duct exploration
During elective open cholecystectomy, a basal commcn dile duct (CBD) manometry was obtained immediately after cholecystectomy, with a 10 Fr. silicone T tube introduced into the cystic duct and connected to a glass manometer.

Outcome Measures

Primary Outcome Measures

  1. Basal common bile duct (CBD) pressure [Intraoperative]

    Basal CBD manometry was obtained immediately after cholecystectomy

  2. First week control common bile duct pressure [First week]

    CBD manometry was obtained one week after cholecystectomy

  3. Second week control common bile duct pressure [Second week]

    CBD manometry was obtained two weeks after cholecystectomy

  4. Third week control common bile duct pressure [Third week]

    CBD manometry was obtained three weeks after cholecystectomy

  5. Fourth week control common bile duct pressure [Fourth week]

    CBD manometry was obtained four weeks after cholecystectomy

  6. Fifth week control common bile duct pressure [Fifth week]

    CBD manometry was obtained five weeks after cholecystectomy

  7. Sixth week control common bile duct pressure [Sixth week]

    CBD manometry was obtained six weeks after cholecystectomy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Choledocholithiasis -

Exclusion Criteria: To not complete the follow-up period

-

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Carlos R. Cervantes Sanchez

Investigators

  • Principal Investigator: David Saldaña-Cortés, MD, General Surgery Service

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Carlos R. Cervantes Sanchez, General Surgery Service, Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
ClinicalTrials.gov Identifier:
NCT04968873
Other Study ID Numbers:
  • 2001/0023
First Posted:
Jul 20, 2021
Last Update Posted:
Jul 20, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Carlos R. Cervantes Sanchez, General Surgery Service, Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2021